Back
Denali Therapeutics Quote, Financials, Valuation and Earnings
The Tech Disruption Wall Street Isn't Talking About...Yet
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
DNLI
Denali Therapeutics
Last Price:
26.52
Seasonality Move:
19.03%
7 Day Trial
ALL ACCESS PASS
$
7
Urgent: The Biggest Gold Bull Market in History Is Here
Click here for urgent details - don't miss out.Denali Therapeutics Price Quote
$26.52
-0.20 (-0.75%)
(Updated: October 9, 2024 at 5:30 PM ET)
Denali Therapeutics Key Stats
Sell
47
Denali Therapeutics (DNLI)
is a Sell
Day range:
$26.30 - $27.47
52-week range:
$14.56 - $32.13
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
11.65
P/B ratio:
2.76%
Volume:
436.5K
Avg. volume:
946.1K
1-year change:
27.79%
Market cap:
$3.8B
Revenue:
$330.5M
EPS:
$-2.85
How Much Does Denali Therapeutics Make?
Data Unavailable
Is Denali Therapeutics Growing As A Company?
Data Unavailable
Denali Therapeutics Stock Price Performance
-
Did Denali Therapeutics Stock Go Up Last Month?
Denali Therapeutics share price went up by 5.82% last month -
Did DNLI's Share Price Rise Over The Last Year?
DNLI share price rose by 27.79% over the past 1 year
What Is Denali Therapeutics 52-Week High & Low?
-
What Is Denali Therapeutics’s 52-Week High Share Price?
Denali Therapeutics has traded as high as $32.13 over the past 52 weeks -
What Is Denali Therapeutics’s 52-Week Low Share Price?
Denali Therapeutics has traded as low as $14.56 over the past 52 weeks
Denali Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Denali Therapeutics?
-
How Much Debt Does Denali Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Denali Therapeutics Have?
Cash and short term investments quarterly total is $896M -
What Is Denali Therapeutics’s Book Value Per Share?
Book value per share is 9.69
Is Denali Therapeutics Cash Flow Positive?
-
What Is DNLI Cash Flow From Operations?
Cash flow from operations (TTM) is -$390.9M -
What Is Denali Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $514.2M -
What Is Denali Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$180.7M
Denali Therapeutics Return On Invested Capital
Data Unavailable
Denali Therapeutics Earnings Date & Stock Price
-
What Is Denali Therapeutics's Stock Price Today?
A single share of DNLI can be purchased today for 26.72 -
What Is Denali Therapeutics’s Stock Symbol?
Denali Therapeutics trades on the nasdaq under the ticker symbol: DNLI -
When Is Denali Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Denali Therapeutics is scheduled on November 7, 2024 -
When Is DNLI's next ex-dividend date?
Denali Therapeutics's next ex-dividend date is October 9, 2024 -
How To Buy Denali Therapeutics Stock?
You can buy Denali Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Denali Therapeutics Competitors
-
Who Are Denali Therapeutics's Competitors?
Below is a list of companies who compete with Denali Therapeutics or are related in some way:
Denali Therapeutics Dividend Yield
-
What Is DNLI Dividend Yield?
Denali Therapeutics’s dividend yield currently is 0% -
What Is Denali Therapeutics’s Payout Ratio?
Denali Therapeutics’s payout ratio is 0% -
When Did Denali Therapeutics Last Pay A Dividend?
The latest dividend pay date is October 9, 2024 -
What Is Denali Therapeutics’s Dividend Per Share?
Denali Therapeutics pays a dividend of $0.00 per share
Denali Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 14.95% |
| Revenue: | 0% | -100% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 2 |
| Sell Recommendations: | 0 |
| Price Target: | 40.62 |
| Upside from Last Price: | 52% |